We are live on
!
Find out more
WSA
Wall Street Associates Portfolio holdings
AUM
$151M
1-Year Est. Return
30.3%
This Fund
S&P 500
This Quarter
Est. Return
-10.74%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$523M
AUM Growth
-$538M
(-51%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-83.99%
Top 10 Holdings %
Top 10 Hldgs %
16.14%
Holding
381
New
50
Increased
12
Reduced
195
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NEOS
Neos Therapeutics, Inc
NEOS
|
+$4.39M |
| 2 |
EGLT
Egalet Corporation
EGLT
|
+$4.21M |
| 3 |
Teladoc Health
TDOC
|
+$3.72M |
| 4 |
FRSH
Papa Murphy's Holdings, Inc
FRSH
|
+$3.37M |
| 5 |
CORI
Corium International, Inc.
CORI
|
+$3.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADPT
Adeptus Health Inc
ADPT
|
+$26.9M |
| 2 |
Repligen
RGEN
|
+$15.8M |
| 3 |
AAC
AAC Holdings
AAC
|
+$15.3M |
| 4 |
TWOU
2U Inc
TWOU
|
+$9.16M |
| 5 |
CALD
Callidus Software, Inc.
CALD
|
+$8.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.22% |
| 2 | Technology | 24.65% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Industrials | 10.1% |
| 5 | Communication Services | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVGR
51
DELISTED
Avinger, Inc. Common Stock
AVGR
| $3.24M | 0.62% |
2
-1
| -33% | -$1.73M |
|
52
Wabash National
WNC
$527M
| $3.19M | 0.61% |
301,284
-185,546
| -38% | -$2.28M |
|
53
Globant
GLOB
$1.61B
| $3.1M | 0.59% |
101,400
-38,300
| -27% | -$1.18M |
|
|
54
Teladoc Health
TDOC
$1.3B
| $3.07M | 0.59% |
+137,876
| New | +$3.72M |
|
55
Entravision Communication
EVC
$1.1B
| $3.06M | 0.58% |
460,258
-350,200
| -43% | -$2.67M |
|
56
Evolent Health
EVH
$447M
| $3.01M | 0.58% |
188,600
-177,000
| -48% | -$3.45M |
|
57
MiMedx Group
MDXG
$633M
| $3M | 0.57% |
310,550
-145,900
| -32% | -$1.54M |
|
58
Marten Transport
MRTN
$1.22B
| $2.97M | 0.57% |
459,125
-331,375
| -42% | -$2.53M |
|
|
USAK
59
DELISTED
USA Truck Inc
USAK
| $2.89M | 0.55% |
167,500
-7,500
| -4% | -$150K |
|
|
FRSH
60
DELISTED
Papa Murphy's Holdings, Inc
FRSH
| $2.87M | 0.55% |
+195,200
| New | +$3.37M |
|
|
CUDA
61
DELISTED
Barracuda Networks, Inc.
CUDA
| $2.84M | 0.54% |
182,196
-33,183
| -15% | -$932K |
|
|
XTLY
62
DELISTED
Xactly Corporation
XTLY
| $2.83M | 0.54% |
362,600
-237,400
| -40% | -$1.79M |
|
|
FLXN
63
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.78M | 0.53% |
187,100
| – | – |
|
|
HLTH
64
DELISTED
Nobilis Health Corp.
HLTH
| $2.73M | 0.52% |
+522,300
| New | +$3M |
|
|
SAAS
65
DELISTED
inContact, Inc.
SAAS
| $2.72M | 0.52% |
362,000
-80,300
| -18% | -$663K |
|
|
SGYP
66
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $2.68M | 0.51% |
505,600
-355,600
| -41% | -$2.75M |
|
|
EXAR
67
DELISTED
Exar Corporation
EXAR
| $2.6M | 0.5% |
436,297
-300,625
| -41% | -$2.12M |
|
68
TechTarget
TTGT
$278M
| $2.54M | 0.49% |
298,000
-221,500
| -43% | -$2.03M |
|
|
ACTA
69
DELISTED
Actua Corp
ACTA
| $2.5M | 0.48% |
213,040
-64,900
| -23% | -$886K |
|
|
CORI
70
DELISTED
Corium International, Inc.
CORI
| $2.48M | 0.48% |
+265,700
| New | +$3.18M |
|
|
RRTS
71
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $2.48M | 0.47% |
5,380
-3,936
| -42% | -$2.27M |
|
|
TCON
72
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $2.44M | 0.47% |
1,250
| – | – |
|
73
Carriage Services
CSV
$569M
| $2.38M | 0.45% |
+110,100
| New | +$2.52M |
|
|
SNAK
74
DELISTED
Inventure Foods, Inc.
SNAK
| $2.28M | 0.44% |
256,800
-203,900
| -44% | -$1.89M |
|
75
Aspen Aerogels
ASPN
$518M
| $2.22M | 0.42% |
+295,726
| New | +$2.15M |
|
Similar funds
CF
VWM
HH
NSCP
EEG
BC
WRHAM
SRP
Wall Street Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Wall Street Associates held 381 positions worth $523M, down 51% from $1.06B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wall Street Associates withdrew a net $439M in Q3 2015, closing 68 positions and reducing 195 holdings. Its most notable exit was AAC Holdings, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Wall Street Associates opened a new position in Neos Therapeutics, Inc worth $4.19M.
- Wall Street Associates's largest Q3 2015 buy was Neos Therapeutics, Inc: 199,343 shares worth $4.19M.
- Wall Street Associates added most to uniQure in Q3 2015, an estimated $780K increase.
- Wall Street Associates's biggest Q3 2015 reduction was Adeptus Health Inc, cutting an estimated $26.9M.
- Wall Street Associates fully exited AAC Holdings in Q3 2015, selling an estimated $15.3M.
- Wall Street Associates's ten largest holdings make up 16% of its $523M portfolio in Q3 2015.
- Wall Street Associates opened 50 new positions and closed 68 in Q3 2015.
- Wall Street Associates's portfolio value fell 51% quarter-over-quarter to $523M.
Based on Wall Street Associates's 13F filing for Q3 2015, filed 12 Nov 2015.